anticancer pipeline

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Energy Alaska governor seeks Korean partners for $44 bn LNG project

Alaska Governor Mike Dunleavy arrived in South Korea on Monday to hold a series of one-on-one meetings with top executives from Korean energy and st...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Bio & Pharma Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

Investment banking Junior bankers choosing track records over name value

A number of junior bankers at the Korean offices of major global investment banks such as Morgan Stanely and J.P.Morgan have resigned since July wit...

Bio & Pharma Huonslab eyes speedy anticancer drug delivery with new patent

South Korean biotech Huons Global Co. said on Tuesday that its research and development unit Huonslab has issued a domestic patent claiming a techno...

Bio & Pharma Celltrion, WuXi XDC to develop new antibody-drug conjugates

South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...

Bio & Pharma Celltrion to export three anticancer drugs to Europe

South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...

Bio & Pharma LG Chem to start phase 3 for head, neck cancer drug in US

South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...

Bio & Pharma Celltrion, Cyron to develop multi-specific antibody new drug

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Bio & Pharma Hanmi Science joins race to develop Wegovy competitor

Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...

Bio & Pharma Voronoi to strengthen AI-driven open innovation

South Korea’s biotechnology startup Voronoi Inc. announced on Monday that it is intensifying its artificial intelligence (AI)-driven new drug ...

Bio & Pharma ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug

New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...

Bio & Pharma Samsung Bioepis to enhance biosimilar presence with Epysqli

FRANKFURT – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is looking to gain ground in the ra...

Hydrogen economy SK Energy opens S.Korea's first hydrogen charging station for large trucks

SK Energy is the first company in South Korea to launch a station for charging large hydrogen-powered trucks. The company on Sunday said it held a c...

Korean chipmakers Korea to raise young chip engineers for Samsung, SK Hynix

South Korea plans to nurture more youths specialized in semiconductors at high schools to ease the worsening shortage of high-skilled workers at d...

Bio & Pharma Korea United Pharm signs contract to supply medicines to Saudi Arabia

Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...

Upcoming IPOs S.Korean companies in renewed push for Kosdaq listings

South Korean companies are making renewed pushes to go public this year even at the expense of reduced IPO values.Zaram Technology Inc., a chip desi...

Bio & Pharma Daewoong, Onchorus to undertake research on mRNA anticancer drugs

Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...

Bio & Pharma Celltrion acquires approval to sell Vegzelma in Canada

South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...

Bio & Pharma Medicox, Oramed sign MOU to enlist more institutional investors

South Korea's biomedicine firm Medicox Co. said on Monday that it had signed a strategic memorandum of understanding (MOU) with Oramed Pharmaceutica...

Bio & Pharma CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...

Bio & Pharma Moderna to stay ahead in mRNA technology: CSO Melissa Moore

CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...

Bio & Pharma SillaJen shares jump as exchange maintains listing, allows resumed trade

Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...

Foreign exchange Falling won yet to cool Koreans’ fever for overseas travel

The South Korean won has continued its decline to hit lows not seen since the 2008-09 global financial crisis on sustained concerns of an economic d...

Steel Steelmaker Husteel's operating profit skyrockets 579% in first half

Shares of Husteel, the only public company within the golf course giant Shinan Group, have doubled in price in the last three months. Industry ...

North Korea Ukraine war gives North Korea reasons to draw closer to Russia

SEOUL—Russia’s invasion of Ukraine has created an opportunity for North Korea, which has strengthened its ties with Moscow and beco...

Bio & Pharma LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials

LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...

Pharmaceuticals Samsung Bioepis posts $1.26 billion in global biosimilar sales

Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said on Friday that sales of its five biosimilar products in global markets, excludi...

Venture Capital Pipeline software solutions provider Cloa wins $5.1 mn in additional funding

NAVER Corp.’s startup accelerator D2SF (D2 Startup Factory) has made an additional investment into data pipeline solutions provider Cloa, the ...